Beranda › Melanoma › Tennessee › Knoxville
Uji klinis Melanoma di Knoxville, TN
5 studi untuk Melanoma mencari peserta di lokasi sekitar Knoxville (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
Menerima pesertaFase 3
- University of Tennessee Medical Center, Knoxville
A Study on How to Safely Guide Surgery for Melanoma and Similar Skin Tumors in Children Using Pathology and Genetic Information
Menerima pesertaFase 2
- East Tennessee Childrens Hospital, Knoxville
Project: Every Child for Younger Patients With Cancer
Menerima pesertaStudi observasional
- East Tennessee Childrens Hospital, Knoxville
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
Menerima pesertaFase 2/3
- University of Tennessee Medical Center, Knoxville
Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
Menerima pesertaFase 3
- University of Tennessee Medical Center, Knoxville
Uji klinis Melanoma di kota lain
- Houston, TX59 studi
- New York City, NY38 studi
- Los Angeles, CA34 studi
- Nashville, TN33 studi
- Pittsburgh, PA31 studi
- Boston, MA26 studi
- Philadelphia, PA23 studi
- San Francisco, CA22 studi
- Durham, NC21 studi
- Salt Lake City, UT21 studi
- St. Louis, MO21 studi
- Columbus, OH21 studi
Studi lain di Knoxville
- Kanker Paru Non-Sel Kecil14 studi
- Obesitas10 studi
- Kanker Paru10 studi
- Kanker Payudara9 studi
- Kanker (semua jenis)8 studi
- Kelebihan Berat Badan7 studi
- Gagal Jantung7 studi
- Kanker Metastatik7 studi
- Penyakit Kardiovaskular6 studi
- Diabetes Tipe 25 studi
- Tekanan Darah Tinggi5 studi
- PPOK5 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.